Papamarkou Wellner Asset Management inc. Buys Shares of 6,443 CME Group Inc. $CME

Posted by Francis Steltz on Aug 28th, 2026

Papamarkou Wellner Asset Management inc. purchased a new stake in CME Group Inc. (NASDAQ:CME – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 6,443 shares of the financial services provider’s stock, valued at approximately $1,903,000. CME Group comprises approximately 0.4% of Papamarkou Wellner Asset Management inc.’s investment portfolio, making the stock its 27th largest holding.

Other institutional investors also recently modified their holdings of the company. Whipplewood Advisors LLC lifted its holdings in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership acquired a new stake in shares of CME Group in the fourth quarter valued at about $27,000. Hilton Head Capital Partners LLC acquired a new position in shares of CME Group in the fourth quarter worth approximately $28,000. Legacy Wealth Managment LLC ID boosted its holdings in CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 71 shares during the last quarter. Finally, Main Street Group LTD bought a new stake in CME Group in the first quarter valued at approximately $32,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In other news, Director William R. Shepard purchased 325 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.30% of the stock is owned by insiders.

CME Group Stock Down 0.0%

Shares of NASDAQ CME opened at $280.94 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $101.02 billion, a PE ratio of 23.83, a P/E/G ratio of 3.34 and a beta of 0.23. The company’s fifty day simple moving average is $253.01 and its 200 day simple moving average is $279.09. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the firm posted $2.96 earnings per share. The business’s revenue was up .8% compared to the same quarter last year. As a group, sell-side analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s payout ratio is presently 44.11%.

Analysts Set New Price Targets

Several research analysts have issued reports on CME shares. The Goldman Sachs Group lowered their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday, June 30th. Barclays decreased their price objective on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research report on Thursday, July 9th. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and lowered their target price for the stock from $286.00 to $270.00 in a research note on Wednesday, August 19th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the company from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, TD Cowen decreased their price target on CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $288.56.

Get Our Latest Report on CME Group

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.